Introduction
Gilbert syndrome (GS) is defined as a fluctuating or discrete elevation of unconjugated serum bilirubin where hemolysis, liver disease or other causes are excluded. Among the general population, Gilbert syndrome is the main cause of unconjugated hyperbilirubinemia [1] . A. Gilbert [2] described this syndrome as a "imple familial jaundice". Thereafter, Meulengracht described Gilbert syndrome as "icterus intermittens juvenilis" [3] , as it is benign and intermittent episodic in character.
In Gilbert syndrome, the mild jaundice occurs as a result of inherited unconjugated hyperbilirubinemia, the most common human metabolic disorders which is caused by polymorphisms in UDP-glucuronosyltransferase 1 (UGT1A1).
UGT is a member of super family of enzymes which catalyzes the glucuronidation of many substrates (both exo and endogenous) and UGT1A1 is also the isozyme that is able to conjugate bilirubin, the endogenous yellow pigment which comes from haeme catabolism [4] . Till to date, more than one hundred variants have been found in the UGT1A1 gene, among them UGT1A1*28, UGT1A1*6 and UGT1A1*27 are associated with the phenotype of Gilbert syndrome [3] [4] [5] . Out of those 3 variants, UGT1A1*28, UGT1A1*6 have been found to be commonly associated in Asian population [6] . The UGT1 gene expresses 9 functional UGT1A proteins, and UGT1A1 is the major protein that catalyzes the glucuronidation [7] . Variants of the UGT1A1 gene polymorphism results in the absence or reduction of UGT1A1 activity which may lead to unconjugated hyperbilirubinemia. The UGT1A1*28 polymorphism occurs as insertion of a thymine-adenine (TA) dinucleotide in the TATAA box of the promoter region and it results in genotype of A(TA)7TAA and A(TA)8TAA, the mutant variety which is opposite of the A(TA)6TAA the wild variety [8] [9] . UGT1A1*28 polymorphism is classified depending on the number of TA repeats in 2 alleles: 1) TA6/TA6 (wild type), 2) TA6/TA7 (heterozygous mutant), or 3) TA7/TA7 (homozygous mutant).
The TA6/TA7 or TA7/TA7 mutants are associated with decreased enzyme activity and, which may account for increased irinotecan related toxicity [10] . UGT1A1 28 has been reported to cause approximately 70 per cent reduction of UGT1A enzyme activity [10] UGT1A1 28 has severe toxicities with irinotecan which is an anti-cancer drug compared to wild type UGT1A1 1 or heterozygous UGT1A1 28. There is ethnic variability in UGT1A1*28 polymorphism. [4] , or glucose-6-phosphate dehydrogenase (G6PD) deficiency [15] , or in β-thalassemia minor (heterozygous) [16] , and it is also associated with neonatal jaundice in G6PD deficiency [17] and hereditary spherocytosis [18] . Genotyping of polymorphisms in UGT1A1 gene is an important step to determine the etiology of free hyperbilirubinemia. Till now, distribution of Gilbert Syndrome (GS) from Bangladesh has not been reported. Therefore, we aimed to determine the genetic profile (prevalence of polymorphisms of UGT1A1) which causes the Gilbert syndrome among Bangladeshi population. 
Materials and Methods

DNA Extraction and Genotyping
Results
Discussion
This is the first ever study where we evaluated the frequency of the main genetic determinant of Gilbert Syndrome (UGT1A1*28 and UGT1A1*6) among Bangladeshi population. Our result confirms that UGT1A1*28 polymorphism is a highly frequent condition among Bangladeshi population. Previously it was believed that, this is not a disease of Bangladeshi population, that's why there was no interest to conduct research on Gilbert syndrome among Bangladeshi population. We believe this finding will completely change the perception level of clinician as well as researcher in Bangladesh. Now a day it is evident that there is an inter-individual and interethnic variation in glucuronidation [19] .
There is a wide range of diversification among UGT family. This is best explained by the UGT1A1 gene, which is responsible for over 50 genetic lesions [20] . It has been reported that, among Caucasian the frequency of the UGT1A1*28 variant allele is 30% -45%. Among African and Indian populations, the distribution is twice that of the 10% -20% reported in East Asian [25] . In Uzbekistan, the incidence of UGT1A1*28 homozygotes was 9.3%, which was higher than that in the Japanese population was studied previously [26] . 
Conclusion
Our study found the evidence of very high prevalence of UGT1A1 polymorphism among Bangladeshi population. This newly discovered result might be the alert for the clinicians treating neonatal jaundice at children hospital in Bangladesh. It is well known that most of the children with Kernicterus have no underlying etiological identity to explain the hyperbilirubinemia. In fact, preventing a case of Kernicterus might be one of the most valuable strategies in all healthcare settings, resulting in a healthy baby rather than a child with a life-time of debilitating neurodevelopment handicaps. UGT1A1 polymorphism also has an implication in case of treatment of cancer. We recommend genotyping of UGT1A1
prior to management of neonatal jaundice as well as before treating by irinotecan chemotherapy as patients with UGT1A1 polymorphism having more adverse effects of this chemotherapeutic agent. Furthermore, study regarding the correlation between prevalence of polymorphism and hyperbilirubinemia is an urgent need.
